Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction
- PMID: 3114911
- DOI: 10.1016/0049-3848(87)90147-2
Elevated levels of the rapid inhibitor of plasminogen activator (t-PAI) in acute myocardial infarction
Abstract
Myocardial infarction is frequently caused by acute coronary thrombosis. A previous study in patients three years after myocardial infarction has shown twice as high concentrations of the rapid inhibitor of plasminogen activator (t-PAI) as in healthy controls. The present study involves 29 patients with acute onset of myocardial infarction. Already on admission the mean concentration of t-PAI was 16.5 +/- 7.4 units/ml as compared to 7.5 +/- 2.3 in healthy controls. It is presently unknown if moderately elevated t-PAI levels contribute to a delay of the spontaneous thrombolysis of the coronary occlusion, thus promoting the development of myocardial infarction.
Similar articles
-
Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.Thromb Haemost. 1988 Dec 22;60(3):372-6. Thromb Haemost. 1988. PMID: 3149044
-
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.Thromb Haemost. 1991 Mar 4;65(3):275-9. Thromb Haemost. 1991. PMID: 1904653
-
Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.N Engl J Med. 1985 Dec 19;313(25):1557-63. doi: 10.1056/NEJM198512193132501. N Engl J Med. 1985. PMID: 3934538
-
Serial changes of plasma plasminogen activator inhibitor activity in acute myocardial infarction: difference between thrombolytic therapy and direct coronary angioplasty.Am Heart J. 1995 Nov;130(5):933-9. doi: 10.1016/0002-8703(95)90191-4. Am Heart J. 1995. PMID: 7484753 Clinical Trial.
-
Functional stability of plasminogen activator inhibitor-1.ScientificWorldJournal. 2014;2014:858293. doi: 10.1155/2014/858293. Epub 2014 Oct 15. ScientificWorldJournal. 2014. PMID: 25386620 Free PMC article. Review.
Cited by
-
Regulation of murine type 1 plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta.J Clin Invest. 1991 Oct;88(4):1346-53. doi: 10.1172/JCI115440. J Clin Invest. 1991. PMID: 1918385 Free PMC article.
-
Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy.Blut. 1989 Jan;58(1):39-43. doi: 10.1007/BF00320234. Blut. 1989. PMID: 2492837
-
Prognostic role of plasminogen-activator-inhibitor-1 levels in treatment with streptokinase of patients with acute myocardial infarction.Clin Cardiol. 2000 Jul;23(7):486-9. doi: 10.1002/clc.4960230723. Clin Cardiol. 2000. PMID: 10894435 Free PMC article.
-
alpha-Fucose-mediated binding and degradation of tissue-type plasminogen activator by HepG2 cells.J Clin Invest. 1994 Feb;93(2):703-10. doi: 10.1172/JCI117023. J Clin Invest. 1994. PMID: 8113404 Free PMC article.
-
Cellular localization of type 1 plasminogen activator inhibitor messenger RNA and protein in murine renal tissue.Am J Pathol. 1993 Jan;142(1):59-70. Am J Pathol. 1993. PMID: 8424466 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical